NEW YORK (Reuters Health) – Among women with invasive ovarian cancer, the presence of BRCA germline mutations is associated with improved survival, according to a
מתוך medicontext.co.il NEW YORK (Reuters Health) – Despite some recommendations that people with celiac disease avoid oats, the results of a study in Finland suggest
מתוך medicontext.co.il NEW YORK (Reuters Health) – Despite some recommendations that people with celiac disease avoid oats, the results of a study in Finland suggest
מתוך medicontext.co.il NEW YORK (Reuters Health) – In patients with acute myocardial infarction (AMI), combined treatment with eptifibatide and low-dose tissue plasminogen activator (t-PA) is
מתוך medicontext.co.il NEW YORK (Reuters Health) – Treating pressure ulcers with a calcium alginate dressing for 4 weeks prior to switching to a hydrocolloid dressing
מתוך medicontext.co.il By Charnicia E. Huggins NEW YORK (Reuters Health) – Night eating syndrome, characterized by a lack of appetite during the day and insomnia
בדיווח של עתון הארץ מוצגי נתוני תמותה חריגים במח' ניתוחי לב בבית חולים "שיבא". יש לציין שהכותרת בעתון הארץ הייתה מטעה שכן התייחסה למחלקת הלב
מיעוט האחיות בפגיות בישראל מעלה הסיכוי להעברת זיהומים בין פגים לכתבה ב "הארץ"
לתכנית הכנס
WASHINGTON (Reuters Health) – Schering-Plough Corp. said on Monday that it received a supplementary approval from the US Food and Drug Administration (FDA) to market
WASHINGTON (Reuters Health) – Schering-Plough Corp. said on Monday that it received a supplementary approval from the US Food and Drug Administration (FDA) to market
מתוך medicontext.co.il WASHINGTON (Reuters Health) – Schering-Plough Corp. said on Monday that it received a supplementary approval from the US Food and Drug Administration (FDA)
By Richard Woodman LONDON (Reuters Health) – Britain's National Institute for Clinical Excellence (NICE) has recommended Schering-Plough's Caelyx for the second-line treatment of advanced ovarian
By Richard Woodman LONDON (Reuters Health) – Britain's National Institute for Clinical Excellence (NICE) has recommended Schering-Plough's Caelyx for the second-line treatment of advanced ovarian
מתוך medicontext.co.il NEW YORK (Reuters Health) – Among patients with a history of heart failure, those who use nonsteroidal anti-inflammatory drugs (NSAIDs) are nearly 10
NEW YORK (Reuters Health) – Among patients with a history of heart failure, those who use nonsteroidal anti-inflammatory drugs (NSAIDs) are nearly 10 times more
מתוך medicontext.co.il NEW YORK (Reuters Health) – Among patients with a history of heart failure, those who use nonsteroidal anti-inflammatory drugs (NSAIDs) are nearly 10
מתוך medicontext.co.il By Martha Kerr SAN ANTONIO (Reuters Health) – Study results presented here Friday night are prompting some Canadian neurologists to campaign against neck
מתוך medicontext.co.il By Martha Kerr SAN ANTONIO (Reuters Health) – Study results presented here Friday night are prompting some Canadian neurologists to campaign against neck
מתוך medicontext.co.il NEW YORK (Reuters Health) – For cases of locally extensive advanced skin squamous carcinoma, novel combination therapy with 13-cis-retinoic acid (13cRA), interferon-alfa (IFN-alfa)